Deborah M. Autor - 29 Jul 2022 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
Director
Signature
/s/ Jason B. Daly, Attorney-in-Fact
Issuer symbol
AMRX
Transactions as of
29 Jul 2022
Net transactions value
$0
Form type
4
Filing time
02 Aug 2022, 21:26:39 UTC
Previous filing
10 Jun 2022
Next filing
11 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Restricted Stock Units Award $0 +54,949 $0.000000 54,949 29 Jul 2022 Class A Common Stock 54,949 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 Restricted stock units vest on the later of (i) the day immediately preceding the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant.